Huajian Medical (01931.HK) and Renhe International have reached a major strategic cooperation to jointly build the world's first vertical RWA exchange focusing on the OTC field.

Financial news from Zhitong APP, Huajian Medical (01931.HK) announced that the group has reached a strategic cooperation with Renhe Pharmaceutical Co., Ltd. (000650.SZ), an indirect wholly-owned subsidiary of Renhe International, to jointly establish the world's first vertical RWA exchange focused on over-the-counter drugs (OTC) in the United States. This cooperation is a key first step and benchmark case in the successful implementation of the group's "ETHK Chain Financial Ecological Strategy" and "Global RWA Exchange Platform" business model, aiming to create a scalable sample to verify the feasibility and enormous potential of this innovative model.